{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:13:00Z","timestamp":1791227580421,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,12,4]],"date-time":"2013-12-04T00:00:00Z","timestamp":1386115200000},"content-version":"vor","delay-in-days":94,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.cllc.2013.03.002","type":"journal-article","created":{"date-parts":[[2013,6,7]],"date-time":"2013-06-07T07:17:07Z","timestamp":1370589427000},"page":"481-487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Toxicity of Concurrent Radiochemotherapy for Locally Advanced Non\u2013Small-Cell Lung Cancer: A Systematic Review of the Literature"],"prefix":"10.1016","volume":"14","author":[{"given":"Caro C.","family":"Koning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne J.","family":"Wouterse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost G.","family":"Daams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lon L.","family":"Uitterhoeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel M.","family":"van den Heuvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 S.","family":"Belderbos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2013.03.002_bib1","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1056\/NEJM199010043231403","article-title":"A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer","volume":"323","author":"Dillman","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cllc.2013.03.002_bib2","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/bmj.311.7010.899","article-title":"Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials","volume":"311","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.cllc.2013.03.002_bib3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/jnci\/83.6.417","article-title":"Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients","volume":"83","author":"Le Chevalier","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cllc.2013.03.002_bib4","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM199202203260805","article-title":"Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer","volume":"326","author":"Schaake-Koning","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cllc.2013.03.002_bib5","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/annonc\/mdj117","article-title":"Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients","volume":"17","author":"Aup\u00e9rin","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cllc.2013.03.002_bib6","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejca.2006.09.005","article-title":"Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973)","volume":"43","author":"Belderbos","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cllc.2013.03.002_bib7","article-title":"Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemoradiation for patients with unresected stage III nsclc: RTOG 9410","volume":"22","author":"Curran","year":"2003","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.cllc.2013.03.002_bib8","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1200\/JCO.2005.03.070","article-title":"Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Fran\u00e7ais de Pneumo-Canc\u00e9rologie NPC 95-01 Study","volume":"23","author":"Fournel","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2013.03.002_bib9","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1200\/JCO.1999.17.9.2692","article-title":"Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer","volume":"17","author":"Furuse","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2013.03.002_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.lungcan.2004.03.004","article-title":"Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study","volume":"46","author":"Zatloukal","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2013.03.002_bib11","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1200\/JCO.2009.26.2543","article-title":"Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer","volume":"28","author":"Aup\u00e9rin","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2013.03.002_bib12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0167-8140(99)00093-6","article-title":"A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial","volume":"52","author":"Ball","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.cllc.2013.03.002_bib13","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/annonc\/mdh100","article-title":"Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study","volume":"15","author":"Groen","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cllc.2013.03.002_bib14","first-page":"47","article-title":"Combined chemoradiotherapy in the treatment of locally advanced non-small cell lung cancer","volume":"7","author":"Isakovi\u0107-Vidovi\u0107","year":"2002","journal-title":"J BUON"},{"key":"10.1016\/j.cllc.2013.03.002_bib15","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1200\/JCO.1998.16.9.3078","article-title":"Southwest Oncology Group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancer","volume":"16","author":"Lau","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2013.03.002_bib16","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1200\/JCO.2006.07.3569","article-title":"Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III non-small-cell lung cancer: cancer and Leukemia Group B","volume":"25","author":"Vokes","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2013.03.002_bib17","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1200\/JCO.1995.13.6.1425","article-title":"Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: a Hoosier Oncology Group protocol","volume":"13","author":"Blanke","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2013.03.002_bib18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.lungcan.2003.09.009","article-title":"A randomised clinical trial of radiotherapy plus cisplatin versus radiotherapy alone in stage III non-small cell lung cancer","volume":"43","author":"Cakir","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2013.03.002_bib19","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1200\/JCO.1995.13.4.869","article-title":"Phase II study of concurrent radiotherapy and chemotherapy for unresectable stage III non-small-cell lung cancer","volume":"13","author":"Furuse","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2013.03.002_bib20","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1158\/1078-0432.CCR-04-0143","article-title":"Uracil\/tegafur plus cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer: a multi-institutional phase II trial","volume":"10","author":"Ichinose","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cllc.2013.03.002_bib21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijrobp.2004.09.038","article-title":"Phase II study of radiotherapy with three-dimensional conformal boost concurrent with paclitaxel and cisplatin for stage IIIB non-small-cell lung cancer","volume":"62","author":"Kim","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2013.03.002_bib22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00432-004-0633-0","article-title":"Concurrent low-dose cisplatin and thoracic radiotherapy in patients with inoperable stage III non-small cell lung cancer: a phase II trial with special reference to the hemoglobin level as prognostic parameter","volume":"131","author":"Pradier","year":"2005","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.cllc.2013.03.002_bib23","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0360-3016(02)02930-9","article-title":"Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in stage III non-small-cell lung cancer","volume":"54","author":"Schild","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2013.03.002_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0360-3016(92)91014-E","article-title":"Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer","volume":"24","author":"Trov\u00f3","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2013.03.002_bib25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0167-8140(92)80128-6","article-title":"Radiotherapy enhanced by cis-platinum in stage III non-small cell lung cancer: a phase II study","volume":"23","author":"Trov\u00f2","year":"1992","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.cllc.2013.03.002_bib26","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1093\/carcin\/17.12.2763","article-title":"In vitro formation of DNA adducts by cisplatin, lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cells","volume":"17","author":"Saris","year":"1996","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cllc.2013.03.002_bib27","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/(SICI)1097-0215(20000320)89:2<160::AID-IJC10>3.0.CO;2-J","article-title":"DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy","volume":"89","author":"van de Vaart","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cllc.2013.03.002_bib28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.radonc.2008.06.003","article-title":"Hearing loss due to concurrent daily low-dose cisplatin chemoradiation for locally advanced head and neck cancer","volume":"89","author":"Zuur","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.cllc.2013.03.002_bib29","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ijrobp.2009.02.034","article-title":"Concurrent chemoradiation with carboplatin-5-fluorouracil versus cisplatin in locally advanced oropharyngeal cancers: is more always better?","volume":"76","author":"Barkati","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2013.03.002_bib30","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00432-008-0532-x","article-title":"Toxicity of daily low dose cisplatin in radiochemotherapy for locally advanced head and neck cancer","volume":"135","author":"Wolff","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.cllc.2013.03.002_bib31","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ijrobp.2007.10.011","article-title":"Toxicity profile and pharmacokinetic study of a phase I low-dose schedule-dependent radiosensitizing paclitaxel chemoradiation regimen for inoperable non-small-cell lung cancer","volume":"71","author":"Chen","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2013.03.002_bib32","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0959-8049(99)00315-9","article-title":"Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small cell lung cancer: results of the EORTC 08912 phase I\/II study","volume":"36","author":"Uitterhoeve","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cllc.2013.03.002_bib33","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/annonc\/mdn559","article-title":"Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study","volume":"20","author":"De Ruysscher","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cllc.2013.03.002_bib34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1748-717X-2-27","article-title":"Accelerated high-dose radiotherapy alone or combined with either concomitant or sequential chemotherapy; treatments of choice in patients with non-small cell lung cancer","volume":"2","author":"Uitterhoeve","year":"2007","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.cllc.2013.03.002_bib35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1200\/JCO.2009.24.7353","article-title":"Tracheoesophageal fistula formation in patients with lung cancer treated with chemoradiation and bevacizumab","volume":"28","author":"Spigel","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2013.03.002_bib36","first-page":"65","article-title":"Cetuximab in combination with single agent daily cisplatin chemotherapy concurrent with radiotherapy in locally advanced nonsmall cell lung carcinoma: a feasibility study","volume":"2","author":"Schaake","year":"2010","journal-title":"Eur J Clin Med Oncol"},{"key":"10.1016\/j.cllc.2013.03.002_bib37","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ijrobp.2010.01.014","article-title":"Phase I trial of radiation with concurrent and consolidation pemetrexed and cisplatin in patients with unresectable stage IIIA\/B non-small-cell lung cancer","volume":"79","author":"Brade","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2013.03.002_bib38","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1097\/JTO.0b013e3181eba657","article-title":"Chemoradiotherapy and gefitinib in stage III non-small cell lung cancer with epidermal growth factor receptor and KRAS mutation analysis: cancer and leukemia group B (CALEB) 30106, a CALGB-stratified phase II trial","volume":"5","author":"Ready","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.cllc.2013.03.002_bib39","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.critrevonc.2008.05.007","article-title":"Combined chemo-radiotherapy for locally advanced non-small cell lung cancer: current status and future development","volume":"68","author":"Guida","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.cllc.2013.03.002_bib40","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/annonc\/mdq316","article-title":"Outcomes of concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer and significant comorbidity","volume":"22","author":"Phernambucq","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cllc.2013.03.002_bib41","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1200\/JCO.2009.24.5050","article-title":"Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105","volume":"28","author":"Yamamoto","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2013.03.002_bib42","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1200\/JCO.2005.07.015","article-title":"Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin and paclitaxel in patients with stage III non-small-cell lung cancer: long-term results of a phase II study","volume":"23","author":"Jeremic","year":"2005","journal-title":"J Clin Oncol"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730413000612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730413000612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:03:39Z","timestamp":1761505419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730413000612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S1525730413000612"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2013.03.002","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxicity of Concurrent Radiochemotherapy for Locally Advanced Non\u2013Small-Cell Lung Cancer: A Systematic Review of the Literature","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2013.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}